I just returned from one of my favorite meetings of the year, the annual American Society of Hematology (ASH) meeting that I have attended almost every year since becoming a cancer researcher in the late 1980s. At the ASH annual meeting, research and clinical advances in blood cancers and other blood disorders are presented and discussed by scientists and physicians. Several presentations at this year’s meeting led me to think about my first ASH meetings.
Advances in technology have allowed us to communicate from a distance more effectively than ever before through videoconferences, webinars, etc. Videoconferencing software including Facetime, Skype, GoToMeeting, and many others are becoming more user-friendly. At the same time, travel to attend meetings is becoming less predictable and more expensive. I have heard talk that these changes will make actual travel to meetings obsolete, and that virtual meetings will be the way of the future. Continue reading